382 filings
Page 5 of 20
SC 13G/A
Sabby Management, LLC
24 Jan 20
Nanoviricides, Inc.
4:12pm
424B1
NNVC
NanoViricides Inc
23 Jan 20
Prospectus with pricing info
9:04pm
EFFECT
NNVC
NanoViricides Inc
10 Jan 20
Notice of effectiveness
12:15am
CORRESP
NNVC
NanoViricides Inc
9 Jan 20
Correspondence with SEC
12:00am
S-1/A
NNVC
NanoViricides Inc
IPO registration (amended)
8 Jan 20
5:15pm
CORRESP
NNVC
NanoViricides Inc
8 Jan 20
Correspondence with SEC
12:00am
S-1/A
NNVC
NanoViricides Inc
IPO registration (amended)
7 Jan 20
12:00am
8-K/A
NNVC
NanoViricides Inc
2 Jan 20
Entry into a Material Definitive Agreement
12:39pm
S-1/A
NNVC
NanoViricides Inc
IPO registration (amended)
23 Dec 19
12:51pm
8-K
NNVC
NanoViricides Inc
19 Dec 19
Entry into a Material Definitive Agreement
4:46pm
FWP
NNVC
NanoViricides Inc
17 Dec 19
Free writing prospectus
12:00am
S-1/A
NNVC
NanoViricides Inc
IPO registration (amended)
17 Dec 19
12:00am
8-K
NNVC
NanoViricides Inc
13 Dec 19
NanoViricides President Dr. Anil Diwan Provides Responses to Shareholder Questions at the Annual Meeting of Shareholders
5:19pm
UPLOAD
NNVC
NanoViricides Inc
9 Dec 19
Letter from SEC
12:00am
S-1
NNVC
NanoViricides Inc
IPO registration
29 Nov 19
12:00am
10-Q
2020 Q1
NNVC
NanoViricides Inc
Quarterly report
15 Nov 19
5:25pm
NT 10-Q
NNVC
NanoViricides Inc
14 Nov 19
Notice of late quarterly filing
1:55pm
8-K
NNVC
NanoViricides Inc
5 Nov 19
NanoViricides Completes Licensing for VZV Field which Includes Shingles Drug Development
9:39pm
RW
NNVC
NanoViricides Inc
5 Nov 19
Registration withdrawal request
9:32pm
DEF 14A
NNVC
NanoViricides Inc
Definitive proxy
28 Oct 19
5:02pm